210 likes | 330 Vues
In 2003, Clonaid claimed to have pioneered human cloning, promoting it as a means for mankind to achieve eternal life, presenting a misguided hope of transferring memories and personality into new bodies. Simultaneously, Urbana Nutrition, Inc. falsely marketed products that claimed to combat aging, despite scientific consensus that no methods currently exist to significantly slow or reverse aging processes. These examples highlight the dangers of scientific misinformation and the need for critical scrutiny in health and technology communications.
E N D
2003 Silver Fleece Awards • The recipients represent “an egregious example of people feeding a line of bull to the public.” 1. Clonaid- Claim to have cloned humans • Says that cloning will “enable mankind to reach eternal life” • Claims that memories and personality will be transferred into a brand new body 2. Urbana Nutrition, Inc. - • Market “Longevity” as anti-aging “There are no methods or products that actually slow, stop or reverse aging” Leonard Hayflick, U. of California, San Francisco Source- AP news, Friday, March 14, 2003
X chromosome inactivation-Review- Panning an Jaenisch, RNA and the epigenetic regulation of X chromosome inactivation. Cell 93:305, 1998 A. Introduction- • Barr bodies first described in females in 1949 • Turners syndrome (45,X) are Barr body negative; Kleinfelters syndrome (47, XXY) are Barr body positive • Lyon hypothesis- one of the two X chromosomes in female is inactivated; all but one is inactivated if multiple X chromosomes - referred to as “dosage compensation”
X chromosome inactivation • Introduction- • X-chromosome inactivation occurs at day 3 of embyrogenesis • Inactivation process is random • Inactivation state maintained throughout life • A few genes remain active in the inactive X chromosome, including XIST at Xq13
Dosage compensation comparisons 1X 1X 2X 2X 2-fold increase in males 2-fold decrease in females Stably inactivate one X chromosome
X chromosome inactivation in flys and worms • Distinct mechanisms to achieve dosage compensation • C. elegans- Dosage compensation by reducing gene activity by two fold on each X chromosome • Mechanism- if one X-, XO-lethal gene is on resulting in male determination • Drosophila- Stimulate X gene transcription 2-fold in males to equal levels from each X • chromosomes in female
Mammals-X-inactivation is used to compensate for 2 X chromosomes Three steps- 1. choice- occurs in embryonic cells • Xist is expressed from both X chromosomes in female • Xist encodes 15 kb polyadenylated untranslated RNA that is unstable • Xist is gene located within Xic
Xist RNA expressed by both X chromosomes Xist Xist Xist RNA interacts with stabilizing factors Xist Blocking factor prevents Xist RNA stablization and spreading Mechanism of Xist-mediated silencing Inactive Active
Inactivated X chromosome Xist RNA
X-inactivation- Step 2 2. initiation- begins at X-inactivation center (Xic) • Xist RNA spreads in cis to coat chromosome • Note that Xist does not interact directly with DNA, but likely through a protein intermediate • Xist gene on other X chromosome is silenced
X-inactivation- Step 3 3. Spread- propagated bidirectionally from Xic • Xist methylation required for silencing of Xist • Dnmt KO- Male X and two female X are all inactivated because Xist gene remains on and Xist RNA coats chromosome
13 p 12 11 12 13 14 q 21 24 mouse autosome X-inactivation- observations • Xist is necessary and sufficient for X inactivation (using 450kb YAC) • insert Xist transgene on autosome results in inactivated autosome
X-inactivation- observations • but Xist is neither necessary or sufficient to maintain X inactivation in somatic cell hybrids • Thus initiation and maintenance of X inactivation are likely distinct mechanisms • Xist maintains inactive state in cis, not trans
Xist Gene Random inactivation Blocking factors Preferential inactivation Prevent inactivation delete X-inactivation Mechanism in mammals • If mutate Xist promoter- preferential X inactivation on chromosome with mutation • possibly due to failure to compete with blocking factor • Delete Xist exons 1-5- mutant chromosome chosen but not inactivated
Mechanism in mammals In Extraembryonic tissues, paternal X is always inactivated • if paternally inherited mutant X – observe no X inactivation in extraembryonic tissue in females • if maternally inherited mutant X - WT phenotype in extraembryonic tissue (i.e .WT X always inactive)
X-inactivation X-controlling element (Xce) mapped to a 6 kb region in Xist gene and is required for X inactivation • Model- Mutually exclusive binding of blocking factor to Xce on one X, and of initiator factor to Xist on other X • Marsupials and in mice extraembyonic tissues- paternal X always inactivated in females Reason???
X-inactivation • Xist RNA may cause replication origins to fire late, resulting in heterochromatin formation • modulate histone acetetylation • The Drosophila mof gene is required for dosage compensation and is an acetyltransferase
Clerc and Avner, Science 290:1518, 2000 X-inactivation is reprogrammed during development Random X inactivation in extraembryonic tissue! Thus, an epigenetic, non-erased tagging must occur normally with male X.
Recall CTCF is involved in genomic imprinting • Recent information- • The factor CTCF may also be involved in X-chromosome choosing. Science 295:345, 2002 CTCF binds and activates XIST anti-sense transcription (called Tsix), which prevents Xist expression, which keeps that X chromosome active